Researchers want to analyze the hepatitis B vaccine in Guinea-Bissau.
A nurse loads a syringe with a vaccine against hepatitis in Lynwood, Calif., on Aug. 27, 2013. Robyn Beck/AFP via Getty Images
|Updated:
A vaccine trial partially funded by the United States is on hold pending a review, African officials announced on Jan. 22.
There is no record of an ethics committee meeting to review the trial, Guinea-Bissau’s Health Minister Quinhi Nantot said during a news conference held by the Africa Centers for Disease Control and Prevention.
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
